merck & co. inc. (MRK:New York)
Thomas Henry Glocer
Director, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee, Merck & Co. Inc.
|Age||Total Calculated Compensation||This person is connected to 92 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Mr. Thomas Henry Glocer, Tom served as the Chief Executive Officer of Thomson Reuters UK Ltd. from July 2001 to January 1, 2012. Mr. Glocer also served as the Chief Executive Officer of Thomson Reuters Corporation from 2008 to January 1, 2012. He joined Reuters Group Plc in 1993 and served as its Vice President and Deputy Counsel of Reuters America and served as an Executive Vice President and General Counsel, Reuters America Holdings since 1995. He served as Chief Executive ...
Corporate Headquarters*One Merck Drive
Whitehouse Station, New Jersey 08889-0100
Board Members Memberships*
Former Chief Executive Officer and Executive Director
Former Chief Executive Officer and Director
Senior Director and Member of Nominating Committee
Director, Chairman of Compensation & Benefits Committee and Member of Governance, Public Policy & Corporate Responsibility Committee
Yale Law School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Severin Schwan||Chief Executive Officer and Director|
Roche Holding AG
|Jean-Paul Agon||Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee|
|€3.9M||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- Chicago, IL | Merck GroupPosted: May 21
- Billerica, MA | Merck GroupPosted: May 25
- Boston, MA | Merck GroupPosted: May 25
- Boston, MA | Merck GroupPosted: May 21